Corridor Pharmaceuticals, Inc. Alternatives & Competitors

12 companies similar to Corridor Pharmaceuticals, Inc. — Pioneering the development and commercialization of therapeutic inhibitors to co...

Panacos Pharmaceuticals

Innovative solutions in the fight against HIV and other viral diseases using advanced smal...

Post-IPO Debt $58.30M

Biotechnology Health Care +1

Nitrase Therapeutics

Pioneering Nitrase Biology and Medicines

13 Series A $45.10M

Brisbane, United States

Biotechnology Health Care +1

Advanced BioDesign

Overcoming Tumor Drug Resistance

20 Venture round $23.30M

Saint-priest, France

Biopharma Biotechnology +2

Incyclix Bio

Regaining Cell Cycle Control

13 Series B $64.00M

Durham, United States

Biotechnology Health Care +2

Track all Corridor Pharmaceuticals, Inc. competitors

Get real-time alerts when any of these companies raise funding, hire, or show growth signals.

See how it works

Flexus Biosciences

Bristol-Myers Squibb acquired Flexus for $800M upfront & $450M in potential earnouts in 20...

1 Venture round $66.20M

Biopharma Biotechnology +1

Selene Therapeutics

Innovative small molecule inhibitors targeting mitochondrial enzymes to address refractory...

2-10 Seed

Biotechnology Health and Wellness

Advenchen Laboratories, LLC

Pioneering novel therapies with promising small molecule kinase inhibitors for a brighter...

6 Venture round $4.48M

Biotechnology Health Care +1

Myricx Bio

Developing a new class of ADCs based on NMT inhibition to treat cancer

36 $1.59B

London, United Kingdom

Biotechnology Health and Wellness +1

ALSP, Inc.

Pioneering small molecule therapies for neurodegenerative diseases, focusing on innovative...

2 Debt Financing $1.15M

La Jolla, United States

Biotechnology Health Care +1

InflaRx

Controlling Inflammation - developing drugs to treat life threatening and chronic inflamma...

46 Post-IPO Equity $250.20M

Jena, Germany

Health Care Health and Wellness +1

Vastera

Pioneering innovative treatments for cardiovascular and cancer diseases through novel redo...

Series B $23.50B

Biotechnology Health Care +1

Cedilla Therapeutics

A New Dimension in Precision Oncology

5 Series B $138.80M

Cambridge, United States

Biotechnology Health Care +1

About Corridor Pharmaceuticals, Inc.

Corridor Pharmaceuticals, Inc. is a biopharmaceutical company that is focused on developing and commercializing therapeutic small molecule inhibitors of arginase, an enzyme that competes with endothelial nitric oxide synthase for l-arginine, a common substrate. The company's arginase also produces ornithine, which elev...

Business keywords

Biopharmaceutical, Therapeutic Inhibitors, Small Molecule Therapies, Arginase Inhibitors, Hyperplasia Treatment, Fibrosis Treatment, Enzyme Inhibition, Polyamine Modulation, Cell Division, Biomedical Innovation, L-Arginine Metabolism, Drug Development, Healthcare Research, Biotech Startups, Medical Therapies

Frequently Asked Questions

Companies similar to Corridor Pharmaceuticals, Inc. include Panacos Pharmaceuticals, Nitrase Therapeutics, Advanced BioDesign, Incyclix Bio, Flexus Biosciences. They work in Biotechnology and Health Care and share Corridor Pharmaceuticals, Inc.'s focus on drug development, biopharmaceutical and biotech startups.

Bounce Watch lists 12 companies that share Corridor Pharmaceuticals, Inc.'s industries and are closest to it in business tags, services, target customers, business model and size.

Don't just read about them. Follow them.

BounceWatch watches Corridor Pharmaceuticals, Inc. and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.

See how it works

Explore Related

Corridor Pharmaceuticals, Inc. Profile Panacos Pharmaceuticals Alternatives Nitrase Therapeutics Alternatives Advanced BioDesign Alternatives All Companies All Signals Trend Reports

Compiled from the BounceWatch company index. We last looked at Corridor Pharmaceuticals, Inc. on 12 Sep 2024. The 12 companies listed here were last checked between 25 Jul 2024 and 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.